“…Specific targets to increase the availability of methyl donor include acceleration of the conversion from homocysteine to methionine. Abnormally high levels of homocysteine have been reported to be a significant risk factor for the development of a wide range of diseases such as in cerebrovascular diseases [ 241 , 242 , 243 , 244 ], various CVDs [ 245 , 246 , 247 , 248 , 249 ], cognitive impairment including Alzheimer’s disease [ 250 , 251 , 252 ], fractures [ 253 , 254 , 255 ], and mortality [ 256 ]. Deficiencies of vitamin B12, folate, or vitamin B6 seem to play an important role in the occurrence of hyperhomocysteinemia, because they are essential for homocysteine metabolism ( Figure 2 ), and treatment with B-vitamin supplementation (B6, B12, and folate) has been demonstrated to effectively lower homocysteine levels [ 257 , 258 , 259 , 260 , 261 ].…”